Resistance to Ibritumomab in Lymphoma - Resistance to Targeted Anti-Cancer Therapeutics -  - Libros - Springer Nature Switzerland AG - 9783030086527 - 8 de enero de 2019
En caso de que portada y título no coincidan, el título será el correcto

Resistance to Ibritumomab in Lymphoma - Resistance to Targeted Anti-Cancer Therapeutics Softcover Reprint of the Original 1st 2018 edition

Precio
$ 107,49
sin IVA

Pedido desde almacén remoto

Entrega prevista 25 de jun. - 8 de jul.
Añadir a tu lista de deseos de iMusic

This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.


158 pages, 11 Tables, color; 14 Illustrations, color; 4 Illustrations, black and white; XIII, 158 p.

Medios de comunicación Libros     Paperback Book   (Libro con tapa blanda y lomo encolado)
Publicado 8 de enero de 2019
ISBN13 9783030086527
Editores Springer Nature Switzerland AG
Páginas 158
Dimensiones 150 × 220 × 10 mm   ·   254 g
Lengua Alemán  
Editor Chatal, Jean-Francois
Editor Hosono, Makoto

Mere med samme udgiver